Major Update On Product Categories For The Next Round Of Competitive Bidding

Published in Government Relations on December 04, 2025

Since the publication of the Final Rules on the Competitive Bidding Program (CBP) was announced, VGM has been in conversation with CMS officials as well as other industry groups regarding additional products being included into the CBP. The unofficial feedback we received indicated that there would be no additional products beyond those reported in the Final Rule.

While there is still a great deal of work to be done in the existing product lines, we are happy to announce that there will be no additional products added to this round of Competitive Bidding. This has been confirmed by CMS in their most recent update here.

To clarify, CMS has updated the fact sheet released November 28 with the Final Rule confirming that "All product categories for the next round will be included in the Nationwide Remote Item Delivery Program.” The fact sheet also states that the urological supplies category will not include hydrophilic catheters. The categories are: 

  • Class II Continuous Glucose Monitors (CGMs) & Insulin Pumps 
  • Urological Supplies 
  • Ostomy Supplies 
  • Hydrophilic Urinary Catheters 
  • Off-the-shelf Back Braces 
  • Off-the-shelf Knee Braces 
  • Off-the-shelf Upper Extremity Braces

This product category limitation marks a significant development for the CBP as legacy items, aside from off-the-shelf knee and back braces, such as oxygen and respiratory equipment, standard wheelchairs, CPAP devices, hospital beds, and other products included in previous bidding rounds WILL NOT be part of the next round. 

“The upcoming round of Competitive Bidding presents significant challenges for patients and providers alike. At VGM, we remain steadfast in defending patients’ rights to choose their healthcare provider and to maintain access to trusted, local services. This recent clarification from CMS enables us to sharpen our message to legislators and industry stakeholders, underscoring the harmful consequences this bidding rule imposes on both patient care and the viability of community-based businesses.” 

– Ike Isaacson, SVP Government & Regulatory Relations for VGM Group, Inc. 

From Our Experts

New Bipartisan Senate Bill Aims to Improve Access to Diabetes Technology & Education for Medicare Beneficiaries thumbnail New Bipartisan Senate Bill Aims to Improve Access to Diabetes Technology & Education for Medicare Beneficiaries U.S. Senators Jeanne Shaheen (D-NH) and Susan Collins (R-ME), Cochairs of the Senate Diabetes Caucus, have introduced the Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act, S.4037. VGM Reintroduces the Fraud, Waste & Abuse Reporting Resource Center thumbnail VGM Reintroduces the Fraud, Waste & Abuse Reporting Resource Center VGM Government Relations is proud to announce the reintroduction of its Fraud, Waste & Abuse (FWA) Reporting Resource Center—a newly refreshed online hub designed to protect the integrity of the DMEPOS industry and reinforce our unwavering commitment to ethical, compliant care. Celebrating Another DME Champion of Change: Thom Harvill of Above and Beyond Medical thumbnail Celebrating Another DME Champion of Change: Thom Harvill of Above and Beyond Medical We're proud to once again recognize a true Champion of Change in the DME industry: Thom Harvill of Above and Beyond Medical in Tennessee. Thom has dedicated many years to the DME community—consistently showing up, speaking out, and pushing the industry forward. He's the kind of advocate who never stops asking, “Who else can I reach out to about this?” Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse thumbnail Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse This week, the Trump administration, through the Centers for Medicare & Medicaid Services (CMS), announced a significant deferral of federal Medicaid matching funds to Minnesota alongside the release of a new Request for Information (RFI) tied to the administration's Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) initiative. These actions along with the changes to DMEPOS accreditation and enrollment signal the administration's aggressive posture on Medicaid and Medicare... VGM Response To CMS Moratorium On New DMEPOS Provider thumbnail VGM Response To CMS Moratorium On New DMEPOS Provider The federal moratorium on new DME suppliers presents a defining moment for us as an industry—an opportunity to demonstrate that the VGM members serving patients are the gold standard. We have long shown that our members operate with integrity, excellence in compliance, and unmatched commitment to service, efficiency, and patient outcomes. Now, we must elevate that message. Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium thumbnail Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium In a press release published on the CMS website Feb. 25, 2026, it was announced that CMS will implement a six-month moratorium on new enrollments for DMEPOS suppliers. Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases thumbnail Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases The DME Medicare Administrative Contractors (MACs) issued a proposed Local Coverage Determination (LCD) change for seat elevation use on group 2 non-complex power wheelchair bases (K0830, K0831 and K0108 on group 2 non-complex HD bases). John Quinlan Named 2026 Van G. Miller Homecare Champion thumbnail John Quinlan Named 2026 Van G. Miller Homecare Champion AAHomecare announced earlier this week that John Quinlan of Quinlan's Pharmacy in New York has been selected as the recipient of this year's Van G. Miller Award. John has been a valued VGM member for many years, and his leadership within the DMEPOS community has made a meaningful impact on patients, providers, and the industry as a whole. His commitment to quality care, patient access, and industry advocacy consistently sets him apart.